Bruker Corporation Declares Quarterly Dividend of $0.05 (NASDAQ:BRKR)

Bruker Corporation (NASDAQ:BRKR) announced a quarterly dividend on Tuesday, November 4th. Investors of record on Monday, December 8th will be given a dividend of 0.05 per share by the medical research company on Friday, January 2nd. This represents a c) annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Monday, December 8th.

Bruker has increased its dividend by an average of 0.0%per year over the last three years. Bruker has a payout ratio of 7.3% meaning its dividend is sufficiently covered by earnings. Analysts expect Bruker to earn $3.15 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.3%.

Bruker Stock Down 0.6%

BRKR traded down $0.23 during trading on Wednesday, hitting $40.15. The company had a trading volume of 489,697 shares, compared to its average volume of 2,828,925. The company has a market cap of $6.09 billion, a PE ratio of 77.27, a P/E/G ratio of 5.31 and a beta of 1.20. The business has a 50-day moving average of $34.65 and a 200-day moving average of $37.01. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.61 and a quick ratio of 0.70. Bruker has a 1-year low of $28.53 and a 1-year high of $64.64.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings results on Monday, November 3rd. The medical research company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.12. The firm had revenue of $860.50 million for the quarter, compared to analysts’ expectations of $847.40 million. Bruker had a net margin of 2.31% and a return on equity of 17.89%. The firm’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the prior year, the company posted $0.60 earnings per share. Bruker has set its FY 2025 guidance at 1.850-1.90 EPS. As a group, analysts forecast that Bruker will post 2.69 earnings per share for the current year.

Insider Buying and Selling at Bruker

In other Bruker news, Director Cynthia M. Friend sold 3,535 shares of the company’s stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $32.25, for a total transaction of $114,003.75. Following the completion of the sale, the director directly owned 18,016 shares of the company’s stock, valued at approximately $581,016. This represents a 16.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 27.30% of the company’s stock.

Institutional Trading of Bruker

A number of hedge funds have recently made changes to their positions in the stock. Hantz Financial Services Inc. lifted its position in shares of Bruker by 774.8% in the third quarter. Hantz Financial Services Inc. now owns 13,647 shares of the medical research company’s stock worth $443,000 after purchasing an additional 12,087 shares in the last quarter. Atlantic Union Bankshares Corp bought a new position in Bruker during the third quarter valued at approximately $188,000. Jones Financial Companies Lllp raised its position in Bruker by 79.7% during the third quarter. Jones Financial Companies Lllp now owns 2,773 shares of the medical research company’s stock valued at $86,000 after acquiring an additional 1,230 shares in the last quarter. Ballast Asset Management LP raised its position in Bruker by 31.4% during the third quarter. Ballast Asset Management LP now owns 69,364 shares of the medical research company’s stock valued at $2,254,000 after acquiring an additional 16,564 shares in the last quarter. Finally, AlphaQuest LLC raised its position in Bruker by 204.6% during the third quarter. AlphaQuest LLC now owns 11,167 shares of the medical research company’s stock valued at $363,000 after acquiring an additional 7,501 shares in the last quarter. 79.52% of the stock is owned by hedge funds and other institutional investors.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.